Race and subset analyses in clinical trials: time to get serious about data integration

Editorial

Blase N Polite et al. J Natl Cancer Inst. 2011.

. 2011 Oct 19;103(20):1486-8.

doi: 10.1093/jnci/djr382. Epub 2011 Oct 12.

No abstract available

Comment on

Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
Yothers G, Sargent DJ, Wolmark N, Goldberg RM, O'Connell MJ, Benedetti JK, Saltz LB, Dignam JJ, Blackstock AW; ACCENT Collaborative Group. Yothers G, et al. J Natl Cancer Inst. 2011 Oct 19;103(20):1498-506. doi: 10.1093/jnci/djr310. Epub 2011 Oct 12. J Natl Cancer Inst. 2011. PMID: 21997132 Free PMC article.

1. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544–573. - PMC - PubMed
1. Soneji S, Iyer SS, Armstrong K, et al. Racial disparities in stage-specific colorectal cancer mortality: 1960-2005. Am J Public Health. 2010;100(10):1912–1916. - PMC - PubMed
1. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence—SEER 9 Regs Research Data, Nov 2010 Sub (1973-2008) <Katrina/Rita Population Adjustment>—Linked To County Attributes—Total U.S., 1969-2009 Counties. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; www.seer.cancer.gov. Released April 2011, based on the November 2010 submission Accessed August 5, 2011.
1. American Cancer Society. Cancer Facts & Figures for African Americans 2009-2010. Atlanta, GA: American Cancer Society; 2009.
1. Baldwin LM, Dobie SA, Billingsley K, et al. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst. 2005;97(16):1211–1220. - PMC - PubMed